Fresenius Kabi iPSUM S.r.l. is the Italian subsidiary of Fresenius Kabi, a global healthcare company with significant CDMO operations specializing in lifesaving medicines for critically and chronically ill patients. The company has extensive FDA-registered manufacturing facilities with 405 FDA-approved products, and provides contract development and manufacturing services for injectable, infusion, and other sterile pharmaceutical products.
Sterile injectables, IV solutions, clinical nutrition, infusion therapy, contract manufacturing
1 site worldwide
Involvement in 14 clinical trials
No certifications on file yet.
No reviews available yet.
No documents available.